Cargando…
The Glycosylated Rv1860 Protein of Mycobacterium tuberculosis Inhibits Dendritic Cell Mediated TH1 and TH17 Polarization of T Cells and Abrogates Protective Immunity Conferred by BCG
We previously reported interferon gamma secretion by human CD4(+) and CD8(+) T cells in response to recombinant E. coli-expressed Rv1860 protein of Mycobacterium tuberculosis (MTB) as well as protection of guinea pigs against a challenge with virulent MTB following prime-boost immunization with DNA...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055742/ https://www.ncbi.nlm.nih.gov/pubmed/24945624 http://dx.doi.org/10.1371/journal.ppat.1004176 |
_version_ | 1782320717661995008 |
---|---|
author | Satchidanandam, Vijaya Kumar, Naveen Jumani, Rajiv S. Challu, Vijay Elangovan, Shobha Khan, Naseem A. |
author_facet | Satchidanandam, Vijaya Kumar, Naveen Jumani, Rajiv S. Challu, Vijay Elangovan, Shobha Khan, Naseem A. |
author_sort | Satchidanandam, Vijaya |
collection | PubMed |
description | We previously reported interferon gamma secretion by human CD4(+) and CD8(+) T cells in response to recombinant E. coli-expressed Rv1860 protein of Mycobacterium tuberculosis (MTB) as well as protection of guinea pigs against a challenge with virulent MTB following prime-boost immunization with DNA vaccine and poxvirus expressing Rv1860. In contrast, a Statens Serum Institute Mycobacterium bovis BCG (BCG-SSI) recombinant expressing MTB Rv1860 (BCG-TB1860) showed loss of protective ability compared to the parent BCG strain expressing the control GFP protein (BCG-GFP). Since Rv1860 is a secreted mannosylated protein of MTB and BCG, we investigated the effect of BCG-TB1860 on innate immunity. Relative to BCG-GFP, BCG-TB1860 effected a significant near total reduction both in secretion of cytokines IL-2, IL-12p40, IL-12p70, TNF-α, IL-6 and IL-10, and up regulation of co-stimulatory molecules MHC-II, CD40, CD54, CD80 and CD86 by infected bone marrow derived dendritic cells (BMDC), while leaving secreted levels of TGF-β unchanged. These effects were mimicked by BCG-TB1860His which carried a 6-Histidine tag at the C-terminus of Rv1860, killed sonicated preparations of BCG-TB1860 and purified H37Rv-derived Rv1860 glycoprotein added to BCG-GFP, but not by E. coli-expressed recombinant Rv1860. Most importantly, BMDC exposed to BCG-TB1860 failed to polarize allogeneic as well as syngeneic T cells to secrete IFN-γ and IL-17 relative to BCG-GFP. Splenocytes from mice infected with BCG-SSI showed significantly less proliferation and secretion of IL-2, IFN-γ and IL-17, but secreted higher levels of IL-10 in response to in vitro restimulation with BCG-TB1860 compared to BCG-GFP. Spleens from mice infected with BCG-TB1860 also harboured significantly fewer DC expressing MHC-II, IL-12, IL-2 and TNF-α compared to mice infected with BCG-GFP. Glycoproteins of MTB, through their deleterious effects on DC may thus contribute to suppress the generation of a TH1- and TH17-dominated adaptive immune response that is vital for protection against tuberculosis. |
format | Online Article Text |
id | pubmed-4055742 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-40557422014-06-18 The Glycosylated Rv1860 Protein of Mycobacterium tuberculosis Inhibits Dendritic Cell Mediated TH1 and TH17 Polarization of T Cells and Abrogates Protective Immunity Conferred by BCG Satchidanandam, Vijaya Kumar, Naveen Jumani, Rajiv S. Challu, Vijay Elangovan, Shobha Khan, Naseem A. PLoS Pathog Research Article We previously reported interferon gamma secretion by human CD4(+) and CD8(+) T cells in response to recombinant E. coli-expressed Rv1860 protein of Mycobacterium tuberculosis (MTB) as well as protection of guinea pigs against a challenge with virulent MTB following prime-boost immunization with DNA vaccine and poxvirus expressing Rv1860. In contrast, a Statens Serum Institute Mycobacterium bovis BCG (BCG-SSI) recombinant expressing MTB Rv1860 (BCG-TB1860) showed loss of protective ability compared to the parent BCG strain expressing the control GFP protein (BCG-GFP). Since Rv1860 is a secreted mannosylated protein of MTB and BCG, we investigated the effect of BCG-TB1860 on innate immunity. Relative to BCG-GFP, BCG-TB1860 effected a significant near total reduction both in secretion of cytokines IL-2, IL-12p40, IL-12p70, TNF-α, IL-6 and IL-10, and up regulation of co-stimulatory molecules MHC-II, CD40, CD54, CD80 and CD86 by infected bone marrow derived dendritic cells (BMDC), while leaving secreted levels of TGF-β unchanged. These effects were mimicked by BCG-TB1860His which carried a 6-Histidine tag at the C-terminus of Rv1860, killed sonicated preparations of BCG-TB1860 and purified H37Rv-derived Rv1860 glycoprotein added to BCG-GFP, but not by E. coli-expressed recombinant Rv1860. Most importantly, BMDC exposed to BCG-TB1860 failed to polarize allogeneic as well as syngeneic T cells to secrete IFN-γ and IL-17 relative to BCG-GFP. Splenocytes from mice infected with BCG-SSI showed significantly less proliferation and secretion of IL-2, IFN-γ and IL-17, but secreted higher levels of IL-10 in response to in vitro restimulation with BCG-TB1860 compared to BCG-GFP. Spleens from mice infected with BCG-TB1860 also harboured significantly fewer DC expressing MHC-II, IL-12, IL-2 and TNF-α compared to mice infected with BCG-GFP. Glycoproteins of MTB, through their deleterious effects on DC may thus contribute to suppress the generation of a TH1- and TH17-dominated adaptive immune response that is vital for protection against tuberculosis. Public Library of Science 2014-06-12 /pmc/articles/PMC4055742/ /pubmed/24945624 http://dx.doi.org/10.1371/journal.ppat.1004176 Text en © 2014 Satchidanandam et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Satchidanandam, Vijaya Kumar, Naveen Jumani, Rajiv S. Challu, Vijay Elangovan, Shobha Khan, Naseem A. The Glycosylated Rv1860 Protein of Mycobacterium tuberculosis Inhibits Dendritic Cell Mediated TH1 and TH17 Polarization of T Cells and Abrogates Protective Immunity Conferred by BCG |
title | The Glycosylated Rv1860 Protein of Mycobacterium tuberculosis Inhibits Dendritic Cell Mediated TH1 and TH17 Polarization of T Cells and Abrogates Protective Immunity Conferred by BCG |
title_full | The Glycosylated Rv1860 Protein of Mycobacterium tuberculosis Inhibits Dendritic Cell Mediated TH1 and TH17 Polarization of T Cells and Abrogates Protective Immunity Conferred by BCG |
title_fullStr | The Glycosylated Rv1860 Protein of Mycobacterium tuberculosis Inhibits Dendritic Cell Mediated TH1 and TH17 Polarization of T Cells and Abrogates Protective Immunity Conferred by BCG |
title_full_unstemmed | The Glycosylated Rv1860 Protein of Mycobacterium tuberculosis Inhibits Dendritic Cell Mediated TH1 and TH17 Polarization of T Cells and Abrogates Protective Immunity Conferred by BCG |
title_short | The Glycosylated Rv1860 Protein of Mycobacterium tuberculosis Inhibits Dendritic Cell Mediated TH1 and TH17 Polarization of T Cells and Abrogates Protective Immunity Conferred by BCG |
title_sort | glycosylated rv1860 protein of mycobacterium tuberculosis inhibits dendritic cell mediated th1 and th17 polarization of t cells and abrogates protective immunity conferred by bcg |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055742/ https://www.ncbi.nlm.nih.gov/pubmed/24945624 http://dx.doi.org/10.1371/journal.ppat.1004176 |
work_keys_str_mv | AT satchidanandamvijaya theglycosylatedrv1860proteinofmycobacteriumtuberculosisinhibitsdendriticcellmediatedth1andth17polarizationoftcellsandabrogatesprotectiveimmunityconferredbybcg AT kumarnaveen theglycosylatedrv1860proteinofmycobacteriumtuberculosisinhibitsdendriticcellmediatedth1andth17polarizationoftcellsandabrogatesprotectiveimmunityconferredbybcg AT jumanirajivs theglycosylatedrv1860proteinofmycobacteriumtuberculosisinhibitsdendriticcellmediatedth1andth17polarizationoftcellsandabrogatesprotectiveimmunityconferredbybcg AT challuvijay theglycosylatedrv1860proteinofmycobacteriumtuberculosisinhibitsdendriticcellmediatedth1andth17polarizationoftcellsandabrogatesprotectiveimmunityconferredbybcg AT elangovanshobha theglycosylatedrv1860proteinofmycobacteriumtuberculosisinhibitsdendriticcellmediatedth1andth17polarizationoftcellsandabrogatesprotectiveimmunityconferredbybcg AT khannaseema theglycosylatedrv1860proteinofmycobacteriumtuberculosisinhibitsdendriticcellmediatedth1andth17polarizationoftcellsandabrogatesprotectiveimmunityconferredbybcg AT satchidanandamvijaya glycosylatedrv1860proteinofmycobacteriumtuberculosisinhibitsdendriticcellmediatedth1andth17polarizationoftcellsandabrogatesprotectiveimmunityconferredbybcg AT kumarnaveen glycosylatedrv1860proteinofmycobacteriumtuberculosisinhibitsdendriticcellmediatedth1andth17polarizationoftcellsandabrogatesprotectiveimmunityconferredbybcg AT jumanirajivs glycosylatedrv1860proteinofmycobacteriumtuberculosisinhibitsdendriticcellmediatedth1andth17polarizationoftcellsandabrogatesprotectiveimmunityconferredbybcg AT challuvijay glycosylatedrv1860proteinofmycobacteriumtuberculosisinhibitsdendriticcellmediatedth1andth17polarizationoftcellsandabrogatesprotectiveimmunityconferredbybcg AT elangovanshobha glycosylatedrv1860proteinofmycobacteriumtuberculosisinhibitsdendriticcellmediatedth1andth17polarizationoftcellsandabrogatesprotectiveimmunityconferredbybcg AT khannaseema glycosylatedrv1860proteinofmycobacteriumtuberculosisinhibitsdendriticcellmediatedth1andth17polarizationoftcellsandabrogatesprotectiveimmunityconferredbybcg |